Matthew 25 Management Corp Pfizer Inc Transaction History

Matthew 25 Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $9.54 Million - $11.3 Million	-205,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $686,250 - $850,350	-15,000 Reduced 6.82%	205,000 $10.6 Million
Q4 2021 Feb 15, 2022	SELL	$41.32 - $61.25 $1.24 Million - $1.84 Million	-30,000 Reduced 12.0%	220,000 $13 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $785,000 - $1.01 Million	-20,000 Reduced 7.41%	250,000 $10.8 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $5.03 Million - $5.7 Million	140,000 Added 107.69%	270,000 $10.6 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $4.35 Million - $4.91 Million	130,000 New	130,000 $4.71 Million

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $165B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Matthew 25 Management Corp, based on Form 13F filings with the SEC.

Stay updated on Matthew 25 Management Corp with notifications on news.